Article
Differential Ability of Spike Protein of SARS-CoV-2 Variants to Downregulate ACE2.
International journal of molecular sciences - 22 Jan 2024
Maeda Yosuke, Toyoda Mako, Kuwata Takeo, Terasawa Hiromi, Tokugawa Umiru, Monde Kazuaki, Sawa Tomohiro, Ueno Takamasa, Matsushita Shuzo
Abstract excerpt
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 19 (COVID-19) and employs angiotensin-converting enzyme 2 (ACE2) as the receptor. Although the expression of ACE2 is crucial for cellular entry, we found that the interaction between ACE2 and the Spike (S) protein in the same cells led to its downregulation through degradation in the lysosomal compartment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
